Last reviewed · How we verify

Conservative Arm

Brighton and Sussex University Hospitals NHS Trust · Phase 3 active Small molecule

The Conservative Arm is a control or standard-of-care comparator group in a clinical trial, not an active pharmaceutical agent.

At a glance

Generic nameConservative Arm
Also known aslow molecular weight heparin,, aspirin,, clopidogrel,, beta blocker (Bisoprolol or equivalent), ACE inhibitor (Ramipril or equivalent)
SponsorBrighton and Sussex University Hospitals NHS Trust
ModalitySmall molecule
PhasePhase 3

Mechanism of action

This appears to be a trial arm designation rather than a drug. In phase 3 trials, a 'Conservative Arm' typically refers to the control group receiving standard medical management, watchful waiting, or minimal intervention, used to benchmark efficacy and safety of an investigational treatment.

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: